Quick Answer
ZIMMER BIOMET HOLDINGS, INC. reported Cash and Equivalents of $591.90 million for fiscal year 2025.
ZIMMER BIOMET HOLDINGS, INC. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $591.90M | +12.6% |
| 2024 | $525.50M | +26.4% |
| 2023 | $415.80M | +10.7% |
| 2022 | $375.70M | -0.6% |
| 2021 | $378.10M | -52.9% |
| 2020 | $802.10M | +29.8% |
| 2019 | $617.90M | +13.8% |
| 2018 | $542.80M | +3.5% |
| 2017 | $524.40M | -17.3% |
| 2016 | $634.10M | -56.5% |
| 2015 | $1.46B | +34.7% |
| 2014 | $1.08B | +0.2% |
| 2013 | $1.08B | +22.2% |
| 2012 | $884.30M | +15.1% |
| 2011 | $768.30M | +14.9% |
| 2010 | $668.90M | -3.3% |
| 2009 | $691.70M | +225.4% |
| 2008 | $212.60M | -54.2% |
| 2007 | $463.90M | +74.6% |
| 2006 | $265.70M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.29B | +127.2% | +132.1% |
| June 30, 2025 | $556.90M | +32.6% | -59.8% |
| March 31, 2025 | $1.38B | +252.3% | +163.5% |
| December 31, 2024 | $525.50M | +26.4% | -7.6% |
| September 30, 2024 | $569.00M | +94.8% | +35.4% |
| June 30, 2024 | $420.10M | +31.4% | +6.9% |
| March 31, 2024 | $393.00M | +19.0% | -5.5% |
| December 31, 2023 | $415.80M | +10.7% | +42.3% |
- ZIMMER BIOMET HOLDINGS, INC. showed an increase of +12.6% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2006–2025 period, ZIMMER BIOMET HOLDINGS, INC.’s cash and equivalents has grown by 122.8% (from $265.70 million to $591.90 million).
- The most recent figure is from ZIMMER BIOMET HOLDINGS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 20, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: